Breaking News Instant updates and real-time market news.

MYL

Mylan

$40.09

0.38 (0.96%)

10:36
06/12/17
06/12
10:36
06/12/17
10:36

Mylan says ISS recommendation on board members 'irrational', Bloomberg reports

  • 03

    Sep

  • 09

    Oct

MYL Mylan
$40.09

0.38 (0.96%)

05/22/17
LEHM
05/22/17
DOWNGRADE
Target $17
LEHM
Equal Weight
Momenta downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Momenta Pharmaceuticals (MNTA) to Equal Weight citing the likelihood of generic manufacturers, most notably Mylan (MYL), winning approval for generic Copaxone in the coming months. The approvals could come before Momenta and its partner Sandoz win approval themselves for the 40mg dose, Tsao tells investors in a research note. He lowered his price target for the shares to $17 from $20.
05/22/17
LEHM
05/22/17
UPGRADE
Target $50
LEHM
Overweight
Mylan upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao upgraded Mylan (MYL) to Overweight saying the chances of the company winning approval for its generic version of Copaxone this year are better than current market expectations. The approval come as soon as next month, Tsao tells investors in a research note. The analyst coupled the upgrade with a downgrade of Copaxone maker Momenta Pharmaceuticals to Equal Weight. The selloff in Mylan following the Q1 disclosure of deficiencies to Advair create a buying opportunity, the analyst contends. He raised his price target for the shares to $50 from $47. Mylan closed Friday down 21c to $37.94.
05/31/17
WELS
05/31/17
NO CHANGE
WELS
Market Perform
Pension fund campaign a short-term negative for Mylan, says Wells Fargo
Wells Fargo analyst David Maris believes the campaign by four major pension funds to oppose the re-election of six directors is short-term negative for Mylan but has the potential to be a longer term positive. The campaign may pose a distraction to management, but if successful, it could address some governance concerns regarding compensation and performance at the company, Maris tells investors in a research note. The analyst has a Market Perform rating on Mylan shares.
06/12/17
SBSH
06/12/17
NO CHANGE
Target $38
SBSH
Buy
Citi says CRL for Coherus not worst case scenario
Citi analyst Mohit Bansal says Coherus Biosciences' (CHRS) complete response letter for its biosimilar version of Neulasta, while "clearly a negative outcome," is not the worst case scenario since the FDA did not ask for another study. The analyst sees a one year delay, which impacts his discounted free cash flow model by $5 per share. Coherus in premarket trading is down 30%, or $6.25, to $14.40. A one year delay would mean Coherus' CHS-1701 could still be on markets at the same time as competition from Mylan (MYL) and ahead of Sandoz's approval in 2019, Bansal tells investors in a research note. The analyst has a Buy rating on Coherus with a $38 price target.

TODAY'S FREE FLY STORIES

ADOM

Adomani

$13.09

0.23 (1.79%)

12:29
08/18/17
08/18
12:29
08/18/17
12:29
Periodicals
TheStreetSweeper calls Adomani 'worst $800 million company ever' 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.88

-12.82 (-26.88%)

12:26
08/18/17
08/18
12:26
08/18/17
12:26
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

12:25
08/18/17
08/18
12:25
08/18/17
12:25
General news
FX Action: Risk-off? No, risk on. USD-JPY popped »

FX Action: Risk-off? No,…

CPN

Calpine

$14.87

1.365 (10.11%)

12:20
08/18/17
08/18
12:20
08/18/17
12:20
Options
Heavy trading in Calpine calls as shares rally »

Heavy trading in Calpine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$19.55

-0.07 (-0.36%)

12:19
08/18/17
08/18
12:19
08/18/17
12:19
Hot Stocks
U.S EEOC sues Macy's for disability discrimination »

The U.S. Equal Employment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

$NSD

NASDAQ Market Internals

12:17
08/18/17
08/18
12:17
08/18/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
08/18/17
08/18
12:16
08/18/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$62.36

0.35 (0.56%)

, XLU

Utilities SPDR

$54.48

0.3 (0.55%)

12:06
08/18/17
08/18
12:06
08/18/17
12:06
Technical Analysis
Technical View: S&P 500 edges above flatline, mid-session update »

The S&P 500 (SPX) was…

XLE

Energy Select Sector SPDR

$62.36

0.35 (0.56%)

XLU

Utilities SPDR

$54.48

0.3 (0.55%)

XLF

Financial Select Sector

$24.72

0.105 (0.43%)

XLK

Technology Select Sector SPDR

$57.33

0.2 (0.35%)

IYR

DJ US Real Estate Index Fund

$79.07

-0.7 (-0.88%)

XLP

Consumer Staples Sector SPDR

$55.25

-0.105 (-0.19%)

XLY

Consumer Discretionary Sector SPDR

$88.62

-0.07 (-0.08%)

SPY

SPDR S&P 500 ETF Trust

$243.52

0.43 (0.18%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$910.98

-15.98 (-1.72%)

, GOOGL

Alphabet Class A

$927.66

-16.61 (-1.76%)

12:04
08/18/17
08/18
12:04
08/18/17
12:04
Hot Stocks
Google launches new machine learning tool to track hate news »

In a blog post…

GOOG

Alphabet

$910.98

-15.98 (-1.72%)

GOOGL

Alphabet Class A

$927.66

-16.61 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

FMAO

Farmers & Merchants

$55.58

-0.17 (-0.30%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
Hot Stocks
Farmers & Merchants board declares two-for-one stock split »

Farmers & Merchants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$117.19

-6.7905 (-5.48%)

, CPN

Calpine

$14.83

1.33 (9.85%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
General news
On The Fly: Top stock stories at midday »

Stocks opened in negative…

DE

Deere

$117.19

-6.7905 (-5.48%)

CPN

Calpine

$14.83

1.33 (9.85%)

GPS

Gap

$22.43

-0.255 (-1.12%)

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

THC

Tenet

$14.04

1.385 (10.95%)

INFY

Infosys

$14.71

-1.22 (-7.66%)

FL

Foot Locker

$34.97

-12.73 (-26.69%)

FINL

Finish Line

$11.99

-0.17 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 18

    Aug

  • 23

    Aug

  • 06

    Sep

  • 06

    Sep

  • 22

    Nov

BC

Brunswick

$50.33

-0.995 (-1.94%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
Options
Call buyers in Brunswick as shares fall »

Call buyers in Brunswick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FL

Foot Locker

$34.98

-12.7201 (-26.67%)

11:59
08/18/17
08/18
11:59
08/18/17
11:59
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

RDUS

Radius Health

$35.42

-1.01 (-2.77%)

11:58
08/18/17
08/18
11:58
08/18/17
11:58
Hot Stocks
Biotech Growth acquires 60,000 more shares of Radius Health »

Biotech Growth NV…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

CVNA

Carvana

$15.12

-0.06 (-0.40%)

11:54
08/18/17
08/18
11:54
08/18/17
11:54
Hot Stocks
Breaking Hot Stocks news story on Carvana »

Carvana drops 3% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

CVNA

Carvana

$15.12

-0.06 (-0.40%)

11:53
08/18/17
08/18
11:53
08/18/17
11:53
Periodicals
Carvana mentioned cautiously by Copperfield Research »

Copperfield Research, in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

11:51
08/18/17
08/18
11:51
08/18/17
11:51
Hot Stocks
Applied Materials CEO says technological shifts in industries to drive growth »

The CEO says has a good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.76

-12.94 (-27.13%)

11:50
08/18/17
08/18
11:50
08/18/17
11:50
Recommendations
Foot Locker analyst commentary  »

Foot Locker comp outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

11:50
08/18/17
08/18
11:50
08/18/17
11:50
General news
Fed's Kaplan sees GDP growth a little above 2% for 2017 »

Fed's Kaplan sees…

AMZN

Amazon.com

$960.57

-17.61 (-1.80%)

, ATVI

Activision Blizzard

$61.37

-1.52 (-2.42%)

11:49
08/18/17
08/18
11:49
08/18/17
11:49
Periodicals
Twitch acquires video indexing platform Clipmine, TechCrunch reports »

Twitch has acquired video…

AMZN

Amazon.com

$960.57

-17.61 (-1.80%)

ATVI

Activision Blizzard

$61.37

-1.52 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 05

    Sep

  • 07

    Sep

FL

Foot Locker

$34.82

-12.88 (-27.00%)

11:45
08/18/17
08/18
11:45
08/18/17
11:45
Downgrade
Foot Locker rating change  »

Wells doubts investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

11:42
08/18/17
08/18
11:42
08/18/17
11:42
Hot Stocks
Applied Materials CEO says much less volatility in chip sector »

The Applied Materials CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.94

-12.76 (-26.75%)

, NKE

Nike

$55.19

-2.27 (-3.95%)

11:41
08/18/17
08/18
11:41
08/18/17
11:41
Recommendations
Foot Locker, Nike, adidas analyst commentary  »

Foot Locker price target…

FL

Foot Locker

$34.94

-12.76 (-26.75%)

NKE

Nike

$55.19

-2.27 (-3.95%)

ADDYY

adidas

$111.98

-1.52 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 03

    Oct

  • 04

    Oct

NBL

Noble Energy

$23.44

0.415 (1.80%)

11:40
08/18/17
08/18
11:40
08/18/17
11:40
Options
Notable put spread in Noble Energy »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

ABCO

The Advisory Board

$51.05

-0.8 (-1.54%)

11:35
08/18/17
08/18
11:35
08/18/17
11:35
Options
Advisory Board put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.